BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, will be joining the National Organization for Rare Disorders (NORD) and other rare disease organizations around the world in observing World Rare Disease Day on February 28 to draw attention to rare diseases as an important global public health concern.
